Analysis of KIR and HLA Polymorphism in Chinese Individuals With COVID ‐19
HLA · 2024
DOI: 10.1111/tan.15715 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Sudan Tao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Transfusion Medicine, Blood Center of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: COVID-19, HLA Antigens, Polymorphism, Genetic, Receptors, KIR. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Zhejiang Provincial Natural Science Foundation of China, NIAID NIH HHS, Science Research Foundation of Zhejiang Healthy Bureau.
Abstract (Originalsprache)
Killer‐cell immunoglobulin‐like receptor (KIR) interactions with HLA class I have crucial roles in modulating NK cell function in response to viral infections. To explore the correlation between KIR/HLA and susceptibility to SARS‐CoV‐2 infection, we analysed polymorphism of KIR genes, haplotypes, HLA allotypes, and the interplay between KIR and HLA in individuals diagnosed with COVID‐19. Compared to a population control group, we observed a significantly increased frequency of KIR3DL3*00802 in the COVID‐19 group. When encoded by the HLA‐B gene, the frequency of HLA‐Bw4, a ligand for KIR3DL1, was at lower frequency in the COVID‐19 group. Additionally, significantly elevated frequencies of KIR‐Bx3 , KIR3DL3*00301 , 3DL3*048 , and C1 + HLA‐C were identified in the COVID‐19 group before multiple test correction, suggesting associations with susceptibility to SARS‐CoV‐2 infection. Our findings indicate that the KIR3DL3*00802 allele may be a high‐risk factor for SARS‐CoV‐2 infection, while Bw4 encoded by HLA‐B gene may confer protective effects against the infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Transfusion Medicine, Blood Center of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
- Department of Biomedical Informatics and Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
ORCID-Profile: Sudan Tao, Lina Dong, Faming Zhu
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- NIAID NIH HHS
- Science Research Foundation of Zhejiang Healthy Bureau
- NIH HHS
- National Science Foundation of China
- National Natural Science Foundation of China
- National Institutes of Health
Zitieren
APA
Tao, S., You, X., Norman, P. J., Kichula, K. M., Dong, L., Chen, N., He, J., Zhang, W., & Zhu, F. (2024). Analysis of KIR and HLA Polymorphism in Chinese Individuals With COVID ‐19. HLA. https://doi.org/10.1111/tan.15715
Vancouver
Tao S, You X, Norman PJ, Kichula KM, Dong L, Chen N, et al. Analysis of KIR and HLA Polymorphism in Chinese Individuals With COVID ‐19. HLA. 2024. doi:10.1111/tan.15715
BibTeX
@article{Tao2024,
author = {Tao, Sudan and You, Xuan and Norman, Paul J and Kichula, Katherine M and Dong, Lina and Chen, Nanying and He, Ji and Zhang, Wei and Zhu, Faming},
title = {Analysis of KIR and HLA Polymorphism in Chinese Individuals With COVID ‐19},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15715}
}
EUVIMED